Skip to content

Clinical trials

Recruiting Phase 1/2 Colorectal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colorectal Neoplasms Phase: Phase 1/2 Status: Recruiting Clear all

108 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20141
20161
20182
20192
20204
20217
20226
202314
202423
202523
202624

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting108

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Revolution Medicines, Inc.4
Cancer Research UK3
Essen Biotech3
National Cancer Institute (NCI)3
A2 Biotherapeutics Inc.2
Betta Pharmaceuticals Co., Ltd.2
BioNTech SE2
Dan Feng2
GlaxoSmithKline2
Jacobio Pharmaceuticals Co., Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colorectal Neoplasms108
Carcinoma, Non-Small-Cell Lung31
Pancreatic Neoplasms26
Stomach Neoplasms22
Ovarian Neoplasms21
Lung Neoplasms19
Neoplasm Metastasis19
Endometrial Neoplasms16
Melanoma15
Neoplasms15

Trials

Showing 1 to 25 of 108. Each trial links to its page on Pharma Observatory.

8 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.